Research / DAKT / Fundamental state Inspectable configuration
State dimensions Filing 0000915779-24-000152 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
31.39% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.58% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.80% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
4.50% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
58.36% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
26.81% · CORE · VALID
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
7.57% · CORE · VALID
R&D intensity 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.72% · OPTIONAL · VALID
SBC intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.25% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 61 states Self-history eligible
Oct 30, 2021 8/8 normalized Level 3 Jan 29, 2022 8/8 normalized Level 3 Apr 30, 2022 8/8 normalized Level 3 Jul 30, 2022 8/8 normalized Level 3 Oct 29, 2022 8/8 normalized Level 3 Jan 28, 2023 8/8 normalized Level 3 Apr 29, 2023 8/8 normalized Level 3 Jul 29, 2023 8/9 normalized Level 3 Oct 28, 2023 8/9 normalized Level 3 Jan 27, 2024 8/9 normalized Level 3 Apr 27, 2024 8/9 normalized Level 3 Jul 27, 2024 8/9 normalized Level 3 Oct 26, 2024 8/9 normalized Level 3 Jan 25, 2025 8/9 normalized Level 3 Apr 26, 2025 8/9 normalized Level 3 Aug 2, 2025 9/9 normalized Level 3 Nov 1, 2025 9/9 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 May 2, 2026 9/9 normalized Level 3 Aug 1, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 33.60%
Current 31.39%
Delta -2.22% Capex Intensity Increased
Previous 2.25%
Current 2.58%
Delta 0.34% Cash Generation Increased
Previous 8.62%
Current 20.80%
Delta 12.19% Growth Increased
Previous -2.77%
Current 4.50%
Delta 7.27% Inventory Pressure Decreased
Previous 59.69%
Current 58.36%
Delta -1.33% Margin Increased
Previous 26.40%
Current 26.81%
Delta 0.41% Profitability Decreased
Previous 10.05%
Current 7.57%
Delta -2.48% R And D Intensity Increased
Previous 4.26%
Current 4.72%
Delta 0.47% Sbc Intensity Increased
Previous 0.23%
Current 0.25%
Delta 0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.